1,3-dinitrobenzene increases expression EXP 6480464 3-dinitrobenzene results in increased expression of PALLD mRNA CTD PMID:21983209 17beta-estradiol increases expression ISO RGD:1604638 6480464 Estradiol results in increased expression of PALLD mRNA CTD PMID:20106945 more ... 17beta-estradiol multiple interactions ISO RGD:1604638 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of PALLD mRNA CTD PMID:30165855 17beta-estradiol decreases expression ISO RGD:1604638 6480464 Estradiol results in decreased expression of PALLD mRNA CTD PMID:19167446 17beta-estradiol affects expression ISO RGD:1604638 6480464 Estradiol affects the expression of PALLD mRNA CTD PMID:14699072 , PMID:22574217 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1604638 6480464 Dihydrotestosterone results in increased expression of PALLD mRNA CTD PMID:29581250 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1312486 6480464 Tetrachlorodibenzodioxin results in increased expression of PALLD mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1312486 6480464 Tetrachlorodibenzodioxin affects the expression of PALLD mRNA CTD PMID:21570461 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1604638 6480464 Tetrachlorodibenzodioxin results in increased expression of PALLD mRNA CTD PMID:26238291 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of PALLD mRNA CTD PMID:23238561 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1312486 6480464 Tetrachlorodibenzodioxin results in decreased expression of PALLD mRNA CTD PMID:23238561 2-butoxyethanol increases expression ISO RGD:1312486 6480464 n-butoxyethanol results in increased expression of PALLD mRNA CTD PMID:19812364 2-butoxyethanol decreases expression ISO RGD:1312486 6480464 n-butoxyethanol results in decreased expression of PALLD mRNA CTD PMID:19812364 4,4'-sulfonyldiphenol affects methylation ISO RGD:1312486 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of PALLD gene CTD PMID:31683443 4-hydroxyphenyl retinamide decreases expression ISO RGD:1312486 6480464 Fenretinide results in decreased expression of PALLD mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects expression ISO RGD:1604638 6480464 Decitabine affects the expression of PALLD mRNA CTD PMID:23300844 aflatoxin B1 affects expression ISO RGD:1604638 6480464 Aflatoxin B1 affects the expression of PALLD protein CTD PMID:20106945 aflatoxin B1 decreases methylation ISO RGD:1604638 6480464 Aflatoxin B1 results in decreased methylation of PALLD gene CTD PMID:27153756 aflatoxin B1 increases expression ISO RGD:1604638 6480464 Aflatoxin B1 results in increased expression of PALLD mRNA CTD PMID:21632981 more ... all-trans-retinoic acid decreases expression ISO RGD:1604638 6480464 Tretinoin results in decreased expression of PALLD mRNA CTD PMID:21934132 all-trans-retinoic acid increases expression ISO RGD:1604638 6480464 Tretinoin results in increased expression of PALLD mRNA CTD PMID:16054129 more ... antirheumatic drug increases expression ISO RGD:1604638 6480464 Antirheumatic Agents results in increased expression of PALLD mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO RGD:1604638 6480464 aristolochic acid I results in decreased expression of PALLD mRNA CTD PMID:33212167 azathioprine increases expression ISO RGD:1604638 6480464 Azathioprine results in increased expression of PALLD mRNA CTD PMID:22623647 benzo[a]pyrene decreases expression ISO RGD:1312486 6480464 Benzo(a)pyrene results in decreased expression of PALLD mRNA CTD PMID:19770486 benzo[a]pyrene decreases methylation ISO RGD:1604638 6480464 Benzo(a)pyrene results in decreased methylation of PALLD promoter CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1604638 6480464 Benzo(a)pyrene affects the methylation of PALLD 5' UTR, Benzo(a)pyrene affects the methylation of PALLD exon CTD PMID:27901495 , PMID:30157460 benzo[a]pyrene increases methylation ISO RGD:1312486 6480464 Benzo(a)pyrene results in increased methylation of PALLD intron CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1604638 6480464 Benzo(a)pyrene results in increased expression of PALLD mRNA CTD PMID:20106945 more ... benzo[a]pyrene decreases expression ISO RGD:1604638 6480464 Benzo(a)pyrene results in decreased expression of PALLD protein CTD PMID:32717239 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1604638 6480464 7 more ... CTD PMID:19150397 benzo[b]fluoranthene decreases expression ISO RGD:1312486 6480464 benzo(b)fluoranthene results in decreased expression of PALLD mRNA CTD PMID:26377693 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PALLD mRNA CTD PMID:25181051 bisphenol A multiple interactions ISO RGD:1604638 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of PALLD gene CTD PMID:31601247 bisphenol A increases expression ISO RGD:1312486 6480464 bisphenol A results in increased expression of PALLD mRNA CTD PMID:32156529 , PMID:33221593 bisphenol A affects expression ISO RGD:1604638 6480464 bisphenol A affects the expression of PALLD mRNA CTD PMID:30903817 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PALLD mRNA CTD PMID:30816183 , PMID:34947998 Bisphenol B increases expression ISO RGD:1604638 6480464 bisphenol B results in increased expression of PALLD protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:1604638 6480464 bisphenol F results in increased expression of PALLD protein CTD PMID:34186270 bortezomib increases expression ISO RGD:1604638 6480464 Bortezomib results in increased expression of PALLD mRNA CTD PMID:20977926 calcitriol decreases expression ISO RGD:1604638 6480464 Calcitriol results in decreased expression of PALLD mRNA CTD PMID:16002434 cannabidiol decreases expression ISO RGD:1604638 6480464 Cannabidiol results in decreased expression of PALLD mRNA CTD PMID:33244087 carbon nanotube decreases expression ISO RGD:1312486 6480464 Nanotubes, Carbon analog results in decreased expression of PALLD mRNA CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:1604638 6480464 CGP 52608 promotes the reaction [RORA protein binds to PALLD gene] CTD PMID:28238834 chloropicrin affects expression ISO RGD:1604638 6480464 chloropicrin affects the expression of PALLD mRNA CTD PMID:26352163 choline multiple interactions ISO RGD:1312486 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PALLD mRNA CTD PMID:20938992 cisplatin affects expression ISO RGD:1604638 6480464 Cisplatin affects the expression of PALLD mRNA CTD PMID:23300844 copper atom multiple interactions ISO RGD:1604638 6480464 [NSC 689534 binds to Copper] which results in increased expression of PALLD mRNA CTD PMID:20971185 copper atom multiple interactions ISO RGD:1312486 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of PALLD mRNA CTD PMID:15467011 copper(0) multiple interactions ISO RGD:1604638 6480464 [NSC 689534 binds to Copper] which results in increased expression of PALLD mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:1312486 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of PALLD mRNA CTD PMID:15467011 copper(II) chloride increases expression ISO RGD:1604638 6480464 cupric chloride results in increased expression of PALLD mRNA CTD PMID:17211630 copper(II) sulfate increases expression ISO RGD:1604638 6480464 Copper Sulfate results in increased expression of PALLD mRNA CTD PMID:19549813 coumarin affects phosphorylation ISO RGD:1604638 6480464 coumarin affects the phosphorylation of PALLD protein CTD PMID:35688186 cyclosporin A increases expression ISO RGD:1312486 6480464 Cyclosporine results in increased expression of PALLD mRNA CTD PMID:19770486 cyclosporin A increases expression ISO RGD:1604638 6480464 Cyclosporine results in increased expression of PALLD mRNA CTD PMID:20106945 more ... deoxynivalenol affects phosphorylation ISO RGD:1312486 6480464 deoxynivalenol affects the phosphorylation of PALLD protein CTD PMID:23811945 dexamethasone increases expression ISO RGD:1604638 6480464 Dexamethasone results in increased expression of PALLD mRNA CTD PMID:25047013 dorsomorphin multiple interactions ISO RGD:1604638 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1312486 6480464 Doxorubicin results in decreased expression of PALLD mRNA CTD PMID:19277126 elemental selenium decreases expression ISO RGD:1604638 6480464 Selenium results in decreased expression of PALLD mRNA CTD PMID:19244175 entinostat decreases expression ISO RGD:1604638 6480464 entinostat results in decreased expression of PALLD mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1604638 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PALLD mRNA CTD PMID:27188386 entinostat increases expression ISO RGD:1604638 6480464 entinostat results in increased expression of PALLD mRNA CTD PMID:27188386 ethanol increases expression ISO RGD:1312486 6480464 Ethanol results in increased expression of PALLD mRNA CTD PMID:30319688 fenamidone increases expression ISO RGD:1312486 6480464 fenamidone results in increased expression of PALLD mRNA CTD PMID:27029645 folic acid multiple interactions ISO RGD:1312486 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PALLD mRNA CTD PMID:20938992 folic acid decreases expression ISO RGD:1312486 6480464 Folic Acid results in decreased expression of PALLD mRNA CTD PMID:25629700 fulvestrant multiple interactions ISO RGD:1604638 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of PALLD gene CTD PMID:31601247 hydrogen peroxide affects expression ISO RGD:1604638 6480464 Hydrogen Peroxide affects the expression of PALLD mRNA CTD PMID:23410634 isoprenaline decreases expression ISO RGD:1312486 6480464 Isoproterenol results in decreased expression of PALLD mRNA CTD PMID:20003209 L-glutamic acid increases expression EXP 6480464 Glutamic Acid results in increased expression of PALLD mRNA CTD PMID:25797319 L-methionine multiple interactions ISO RGD:1312486 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PALLD mRNA CTD PMID:20938992 leflunomide increases expression ISO RGD:1604638 6480464 leflunomide results in increased expression of PALLD mRNA CTD PMID:28988120 menadione affects expression ISO RGD:1604638 6480464 Vitamin K 3 affects the expression of PALLD mRNA CTD PMID:23410634 mercury dibromide increases expression ISO RGD:1604638 6480464 mercuric bromide results in increased expression of PALLD mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1604638 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PALLD mRNA CTD PMID:27188386 methamphetamine increases expression ISO RGD:1312486 6480464 Methamphetamine results in increased expression of PALLD mRNA CTD PMID:26307267 methotrexate increases expression ISO RGD:1604638 6480464 Methotrexate results in increased expression of PALLD mRNA CTD PMID:24449571 methyl methanesulfonate increases expression ISO RGD:1604638 6480464 Methyl Methanesulfonate results in increased expression of PALLD mRNA CTD PMID:23649840 methylmercury chloride increases expression ISO RGD:1604638 6480464 methylmercuric chloride results in increased expression of PALLD mRNA CTD PMID:23179753 more ... methylmercury chloride multiple interactions ISO RGD:1604638 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PALLD mRNA CTD PMID:27188386 nickel sulfate decreases expression ISO RGD:1604638 6480464 nickel sulfate results in decreased expression of PALLD mRNA CTD PMID:22714537 p-chloromercuribenzoic acid increases expression ISO RGD:1604638 6480464 p-Chloromercuribenzoic Acid results in increased expression of PALLD mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:1604638 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PALLD mRNA CTD PMID:27188386 paracetamol affects expression ISO RGD:1312486 6480464 Acetaminophen affects the expression of PALLD mRNA CTD PMID:17562736 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of PALLD mRNA CTD PMID:32680482 phenylmercury acetate increases expression ISO RGD:1604638 6480464 Phenylmercuric Acetate results in increased expression of PALLD mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1604638 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PALLD mRNA CTD PMID:27188386 pirinixic acid decreases expression ISO RGD:1312486 6480464 pirinixic acid results in decreased expression of PALLD mRNA CTD PMID:17426115 pirinixic acid increases expression ISO RGD:1312486 6480464 pirinixic acid results in increased expression of PALLD mRNA CTD PMID:18301758 piroxicam decreases expression ISO RGD:1604638 6480464 Piroxicam results in decreased expression of PALLD mRNA CTD PMID:21858171 potassium chromate decreases expression ISO RGD:1604638 6480464 potassium chromate(VI) results in decreased expression of PALLD mRNA CTD PMID:22714537 propanal decreases expression ISO RGD:1604638 6480464 propionaldehyde results in decreased expression of PALLD mRNA CTD PMID:26079696 propiconazole increases expression ISO RGD:1312486 6480464 propiconazole results in increased expression of PALLD mRNA CTD PMID:21278054 quercetin increases expression ISO RGD:1604638 6480464 Quercetin results in increased expression of PALLD mRNA CTD PMID:21632981 quinolin-8-ol increases expression ISO RGD:1604638 6480464 Oxyquinoline results in increased expression of PALLD mRNA CTD PMID:21632981 raloxifene affects expression ISO RGD:1604638 6480464 Raloxifene Hydrochloride affects the expression of PALLD mRNA CTD PMID:14699072 SB 431542 multiple interactions ISO RGD:1604638 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 selenium atom decreases expression ISO RGD:1604638 6480464 Selenium results in decreased expression of PALLD mRNA CTD PMID:19244175 silver atom increases expression ISO RGD:1604638 6480464 Silver results in increased expression of PALLD mRNA CTD PMID:26014281 silver(0) increases expression ISO RGD:1604638 6480464 Silver results in increased expression of PALLD mRNA CTD PMID:26014281 sodium arsenite decreases expression ISO RGD:1604638 6480464 sodium arsenite results in decreased expression of PALLD mRNA CTD PMID:34032870 sunitinib decreases expression ISO RGD:1604638 6480464 Sunitinib results in decreased expression of PALLD mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:1604638 6480464 Tamoxifen affects the expression of PALLD mRNA CTD PMID:14699072 tamoxifen increases expression ISO RGD:1312486 6480464 Tamoxifen results in increased expression of PALLD mRNA CTD PMID:17555576 tebuconazole decreases expression ISO RGD:1604638 6480464 tebuconazole results in decreased expression of PALLD mRNA CTD PMID:30458266 tert-butyl hydroperoxide affects expression ISO RGD:1604638 6480464 tert-Butylhydroperoxide affects the expression of PALLD mRNA CTD PMID:23410634 testosterone enanthate affects expression ISO RGD:1604638 6480464 testosterone enanthate affects the expression of PALLD mRNA CTD PMID:17440010 tetrachloromethane increases expression ISO RGD:1312486 6480464 Carbon Tetrachloride results in increased expression of PALLD mRNA CTD PMID:31919559 tetrahydropalmatine decreases expression ISO RGD:1604638 6480464 tetrahydropalmatine results in decreased expression of PALLD protein CTD PMID:20109541 tetraphene decreases expression ISO RGD:1312486 6480464 benz(a)anthracene results in decreased expression of PALLD mRNA CTD PMID:26377693 thapsigargin increases expression EXP 6480464 Thapsigargin results in increased expression of PALLD protein CTD PMID:35544339 titanium dioxide increases expression ISO RGD:1312486 6480464 titanium dioxide results in increased expression of PALLD mRNA CTD PMID:29264374 torcetrapib increases expression ISO RGD:1604638 6480464 torcetrapib results in increased expression of PALLD mRNA CTD PMID:23228038 trichostatin A decreases expression ISO RGD:1604638 6480464 trichostatin A results in decreased expression of PALLD mRNA CTD PMID:26272509 trichostatin A affects expression ISO RGD:1604638 6480464 trichostatin A affects the expression of PALLD mRNA CTD PMID:28542535 trichostatin A multiple interactions ISO RGD:1604638 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PALLD mRNA CTD PMID:27188386 triptonide decreases expression ISO RGD:1312486 6480464 triptonide results in decreased expression of PALLD mRNA CTD PMID:33045310 valproic acid affects expression ISO RGD:1604638 6480464 Valproic Acid affects the expression of PALLD mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1604638 6480464 Valproic Acid results in increased expression of PALLD mRNA CTD PMID:19101580 more ... vorinostat decreases expression ISO RGD:1604638 6480464 vorinostat results in decreased expression of PALLD mRNA CTD PMID:27188386
